Pmv Pharmaceuticals Inc (PMVP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $95.93M
Last updated: Nov 17, 2026 at 11:06 AM ET
Pmv Pharmaceuticals Inc (PMVP) Competitors
The companies most similar to Pmv Pharmaceuticals are PDS Biotechnology (PDSB), Molecular Partners AG ADR (MOLN) and PolyPid (PYPD). By market cap, Pmv Pharmaceuticals ranks 8th of the 13 companies on this page; MacroGenics (MGNX) is the largest at $140.60M.
Peer Comparison
PMVP's revenue growth of 0.0% is above the peer median of -25.9%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PDS Biotechnology Corp (PDSB) | $107.07M | N/A | N/A | 0.0% | -149.8% | 0.0% | 0.00% |
| Molecular Partners AG ADR (MOLN) | $112.71M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| PolyPid (PYPD) | $132.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Milestone Pharmaceuticals Inc (MIST) | $64.74M | N/A | 8.6x | 0.0% | -133.9% | -100.0% | 0.00% |
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Vivani Medical Inc. (VANI) | $91.11M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Minerva Neurosciences Inc (NERV) | $114.62M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Voyager Therapeutics Inc (VYGR) | $107.66M | N/A | 4.0x | 0.0% | N/A | -70.0% | 0.00% |
| MacroGenics Inc (MGNX) | $140.60M | N/A | 1.2x | -36.6% | -108.7% | -64.8% | 0.00% |
| Verrica Pharmaceuticals Inc (VRCA) | $61.16M | N/A | 3.0x | -189.2% | -496.2% | -51.8% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Peer median | $103.81M | N/A | 3.5x | 0.0% | -205.1% | -25.9% | 0.00% |
Similar Companies
These are the 12 companies most similar to Pmv Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| PDS Biotechnology Corp (PDSB) | PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. | PDSB competitors |
| Molecular Partners AG ADR (MOLN) | Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland. | MOLN competitors |
| PolyPid (PYPD) | PolyPid Ltd., an advanced stage biopharmaceutical company, develops, manufactures and markets products based on the Polymer Lipid Encapsulation Matrix (PLEX)... | PYPD competitors |
| Milestone Pharmaceuticals Inc (MIST) | Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. | MIST competitors |
| OUTLOOK THERAPEUTICS INC (OTLK) | Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic... | OTLK competitors |
| Vivani Medical Inc. (VANI) | Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery... | VANI competitors |
| Minerva Neurosciences Inc (NERV) | Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products... | NERV competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| Voyager Therapeutics Inc (VYGR) | Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. | VYGR competitors |
| MacroGenics Inc (MGNX) | MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. | MGNX competitors |
| Verrica Pharmaceuticals Inc (VRCA) | Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. | VRCA competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
Frequently Asked Questions About PMVP
Who are Pmv Pharmaceuticals' main competitors?
The companies most similar to Pmv Pharmaceuticals include PDS Biotechnology (PDSB), Molecular Partners AG ADR (MOLN), PolyPid (PYPD), Milestone Pharmaceuticals (MIST) and OUTLOOK THERAPEUTICS INC (OTLK), listed from the closest match.
Who is Pmv Pharmaceuticals' biggest competitor?
MacroGenics (MGNX) is the largest of the similar companies at $140.60M; PDS Biotechnology (PDSB) is the closest match by business profile, size, sector and industry.
How does PMVP stock compare with its competitors?
PMVP's net margin is 0.0% against a peer median of 0.0%.
Which of Pmv Pharmaceuticals' competitors pays a higher dividend?
Pmv Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Pmv Pharmaceuticals bigger than its competitors?
No. Pmv Pharmaceuticals is 8th by market cap among the 13 companies on this page; the largest is MacroGenics (MGNX) at $140.60M.
PMVP pages: Overview, Earnings, Forecast, Financials, Competitors